Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             104 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens Jerlhag, Elisabet
 2008
 18 Supplement 4 p. 508-518
11 p.
 artikel
2 C.08.03 Are extended-release oral antipsychotics improving patient outcomes? Current data with new formulations Schreiner, A.
 2008
 18 Supplement 4 p. S596-
1 p.
 artikel
3 C.03.02 Early predictors–areviewofcurrent knowledge Leucht, S.
 2008
 18 Supplement 4 p. S590-S591
2 p.
 artikel
4 C.22.01 Environmental and genetic vulnerability factors in bipolar disorders: implications for everyday clinical practice Leboyer, M.
 2008
 18 Supplement 4 p. S612-
1 p.
 artikel
5 C.12.03 Novel long term treatments for bipolar disorder Stahl, S.M.
 2008
 18 Supplement 4 p. S601-
1 p.
 artikel
6 C.13.03 Pharmacotherapy of generalised anxiety disorder and associated comorbidities Allgulander, C.
 2008
 18 Supplement 4 p. S602-
1 p.
 artikel
7 C.23.01 Remission as the goal of antidepressant therapies: where are we today? Lebowitz, B.
 2008
 18 Supplement 4 p. S613-
1 p.
 artikel
8 C.18.01 Use of adjunct therapy in the maintenance treatment of bipolar disorder Vieta, E.
 2008
 18 Supplement 4 p. S607-
1 p.
 artikel
9 ECNP announcement - Young scientists 2008
 18 Supplement 4 p. II-
1 p.
 artikel
10 ECNP Calendar of Events 2008
 18 Supplement 4 p. I-
1 p.
 artikel
11 ECNP Calendar of Events 2008
 18 Supplement 4 p. I-
1 p.
 artikel
12 ECNP Calendar of Events 2008
 18 Supplement 4 p. 234-
1 p.
 artikel
13 ECNP consensus meeting. Bipolar depression. Nice, March 2007 Goodwin, Guy M.
 2008
 18 Supplement 4 p. 535-549
15 p.
 artikel
14 E.01.01 Prescribing for unlicensed applications Kosky, N.
 2008
 18 Supplement 4 p. S199-
1 p.
 artikel
15 Factors triggering abolishment of benzodiazepines effects in the four-plate test–retest in mice Petit-Demoulière, B.
 2008
 18 Supplement 4 p. 41-47
7 p.
 artikel
16 Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST) Leggio, Gian Marco
 2008
 18 Supplement 4 p. 271-277
7 p.
 artikel
17 P.1.a.007 A genetic assessment of antipsychotic and antidepressant cardiac iatrogenicity: focus on the proarrhythmic profile Drago, A.
 2008
 18 Supplement 4 p. S206-
1 p.
 artikel
18 P.7.a.006 Alteration of EEG characteristics in epileptic children during the treatment with antiepileptic drugs (carbamazepine) Khachidze, I.
 2008
 18 Supplement 4 p. S557-S558
2 p.
 artikel
19 P.3.a.014 Assessing remission in schizophrenia patients treated with long-acting risperidone in clinical practice Peuskens, J.
 2008
 18 Supplement 4 p. S393-
1 p.
 artikel
20 P.2.a.027 Association between tryptophan hydroxylase 2 gene and the personality traits of novelty seeking and harm avoidance Nam, Y.Y.
 2008
 18 Supplement 4 p. S307-S308
2 p.
 artikel
21 P.1.a.021 Association of GRIK4 and HTR2A genes with antidepressant treatment in the MARS cohort of depressed inpatients Horstmann, S.
 2008
 18 Supplement 4 p. S214-S215
2 p.
 artikel
22 P.2.a.003 Baseline severity of depression predicts antidepressant drug response Wade, A.G.
 2008
 18 Supplement 4 p. S294-
1 p.
 artikel
23 P.8.a.010 Change of suicide completion related factors through current 4 years Kim, S.J.
 2008
 18 Supplement 4 p. S572-
1 p.
 artikel
24 P.1.a.004 Chromosomal aberrations in an African schizophrenia population Koen, L.
 2008
 18 Supplement 4 p. S204-S205
2 p.
 artikel
25 P.3.a.017 Decreased serum pro BDNF/BDNF ratio in patients with schizophrenia Carlino, D.
 2008
 18 Supplement 4 p. S395-
1 p.
 artikel
26 P.8.a.032 ECG changes during sertindole treatment Nielsen, J.
 2008
 18 Supplement 4 p. S585-
1 p.
 artikel
27 P.5.a.004 Efficacy of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis Kani, C.
 2008
 18 Supplement 4 p. S505-
1 p.
 artikel
28 P.8.a.018 Hypothalamic-pituitary-adrenal (HPA) axis function and stress-related disorders Dell'Osso, M. Catena
 2008
 18 Supplement 4 p. S577-
1 p.
 artikel
29 P.8.a.001 Interactions of alternative medicine and psychopharmacologic drugs Habermeyer, E.
 2008
 18 Supplement 4 p. S567-
1 p.
 artikel
30 P.7.a.009 Long-term effectiveness and safety of lisdexamfetamine dimesylate in children aged 6−12 with attention-deficit/hyperactivity disorder McGough, J.
 2008
 18 Supplement 4 p. S559-
1 p.
 artikel
31 P.5.a.007 Memantine decreases, and prevents the emergence of, key behavioural symptoms of Alzheimer's disease Wilkinson, D.
 2008
 18 Supplement 4 p. S507-
1 p.
 artikel
32 P.2.a.013 Outcome situations of patients, after admission at the emergency room, with suicidal attempt Minner, P.
 2008
 18 Supplement 4 p. S299-S300
2 p.
 artikel
33 P.4.a.003 The characteristics of salivary alpha-amylase reactivity to negative affective pictures Lee, S.J.
 2008
 18 Supplement 4 p. S479-
1 p.
 artikel
34 P.8.a.015 The effect of lamotrigine co-medication on seizure occurrence: basal versus ictal serum levels Almeida, A.
 2008
 18 Supplement 4 p. S575-
1 p.
 artikel
35 P.6.a.011 Tiagabine in the treatment of alcoholism: a pilot study Paparrigopoulos, T.
 2008
 18 Supplement 4 p. S525-
1 p.
 artikel
36 P.4.b.005 Effects of antidepressants on deficit in spontaneous alternation caused by agonists of DA receptors in nucleus accumbens Papp, M.
 2008
 18 Supplement 4 p. S489-
1 p.
 artikel
37 P.4.b.002 Effects of imipramine repeated treatment on BDNF levels in the dorsal periaqueductal gray matter and hippocampus Casarotto, P.C.
 2008
 18 Supplement 4 p. S487-S488
2 p.
 artikel
38 P.2.05 Behavioural responses to morphine in mutants with progressive ablation of D1 receptor-expressing cells Babovic, D.
 2008
 18 Supplement 4 p. s40-s41
nvt p.
 artikel
39 P.3.b.011 QTc interval in a sample of chronic schizophrenic inpatients Paz-Silva, E.
 2008
 18 Supplement 4 p. S403-S404
2 p.
 artikel
40 P.2.b.008 The effects of antidepressants on the expression of UCP-1,2,3 mRNA in the animal model of metabolic syndrome Jeon, H.T.
 2008
 18 Supplement 4 p. S317-
1 p.
 artikel
41 P.6.b.008 Treatment of alcoholic patients with original anticonvulsant alters alcohol motivation and progesterone level in plasma Shushpanova, T.
 2008
 18 Supplement 4 p. S531-
1 p.
 artikel
42 P.2.c.018 ACTH and cortisol in major depressive disorders: antidepressant responders and non-responders Jeon, Y.
 2008
 18 Supplement 4 p. S334-S335
2 p.
 artikel
43 P.1.c.049 Alertness and electrocortical activity after (co-)administration of MDMA and THC in healthy volunteers Lansbergen, M.M.
 2008
 18 Supplement 4 p. S247-S248
2 p.
 artikel
44 P.2.c.004 Antidepressants are associated with increased length of hypnotic use in primary care Donoghue, J.
 2008
 18 Supplement 4 p. S326-S327
2 p.
 artikel
45 P.2.c.001 Antidepressant treatment in a primary mental health center – tolerability and clinical improvement – patients opinion Falces, A.
 2008
 18 Supplement 4 p. S325-
1 p.
 artikel
46 P.3.c.023 Cannabidiol for the treatment of psychosis in Parkinson's disease Zuardi, A.W.
 2008
 18 Supplement 4 p. S417-S418
2 p.
 artikel
47 P.6.c.013 Cannabis effects on cognition and psychomotor function in daily cannabis users Theunissen, E.L.
 2008
 18 Supplement 4 p. S539-
1 p.
 artikel
48 P.3.c.069 Day 4 partial response to ziprasidone predicts later treatment response in patients with bipolar disorder Pappadopulos, E.
 2008
 18 Supplement 4 p. S443-S444
2 p.
 artikel
49 P.3.c.041 Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis Cruz, N.
 2008
 18 Supplement 4 p. S427-
1 p.
 artikel
50 P.4.08 Changes of the phosphorylated form of tau and related signal transduction in young APPswe transgenic mice Mustafiz, T.
 2008
 18 Supplement 4 p. s91-
1 p.
 artikel
51 P.3.c.058 Interim-analysis of a long-term treatment study with long-acting injectable risperidone and oral second generation antipsychotics in schizophrenia Ibach, B.
 2008
 18 Supplement 4 p. S437-
1 p.
 artikel
52 P.1.c.008 Is a dual mechanism of action better than a single one in the inhibition of nociception by antidepressants? Suciu, R.
 2008
 18 Supplement 4 p. S224-S225
2 p.
 artikel
53 P.3.c.027 Metabolic syndrome, cardiovascular risk and antipsychotic treatment in schizophrenic patients Castaño, J.
 2008
 18 Supplement 4 p. S419-
1 p.
 artikel
54 P.1.c.022 Pharmacological characterization of ghrelin receptor in rat adenoma anterior pituitary cell line, RC-4B/C Perdona, E.
 2008
 18 Supplement 4 p. S232-S233
2 p.
 artikel
55 P.3.c.072 Polymorphisms of the 5HT2A and D2 receptor genes and weight change during olanzapine treatment Olajossy-Hilkesberger, L.
 2008
 18 Supplement 4 p. S445-
1 p.
 artikel
56 P.3.c.013 Risperidone long acting injection: 2 year outcomes in a naturalistic study Deslandes, P.
 2008
 18 Supplement 4 p. S411-S412
2 p.
 artikel
57 P.1.c.005 Role of 5-HT2A/2C serotonergic receptors in the anterior pretectal nucleus electric stimulation-induced antinociception Carvalho, A.D.
 2008
 18 Supplement 4 p. S223-
1 p.
 artikel
58 P.2.c.033 The efficacy of desvenlafaxine for improving functioning and quality of life measures in patients with major depressive disorder Soares, C.
 2008
 18 Supplement 4 p. S342-S343
2 p.
 artikel
59 P.3.c.055 The incidence of metabolic syndrome and its reversibility in patients with psychotic disorders followed for one year Schorr, S.
 2008
 18 Supplement 4 p. S435-S436
2 p.
 artikel
60 P.2.c.036 Treatment compliance and health care costs of medicaid depressed adult patients treated with escitalopram versus citalopram Erder, M.H.
 2008
 18 Supplement 4 p. S344-
1 p.
 artikel
61 P.1.d.015 Behavioral, proliferative and molecular correlations in the rat chronic mild stress model of depression Wiborg, O.
 2008
 18 Supplement 4 p. S257-
1 p.
 artikel
62 P.3.d.012 Can high dose related toxicity restrict the neuroprotective effect of risperidone and olanzapine: an experimental study? Yulug, B.
 2008
 18 Supplement 4 p. S455-
1 p.
 artikel
63 P.1.d.012 Comparison of donepezile, ispronicline, varenicline and vinpocetine in two types of learning paradigms in rodents Laszy, J.
 2008
 18 Supplement 4 p. S255-
1 p.
 artikel
64 P.2.d.013 F15599, a post-synaptic cortical preferential 5-HT1A agonist: I) functionally-selective signal transduction profile Newman-Tancredi, A.
 2008
 18 Supplement 4 p. S352-S353
2 p.
 artikel
65 P.6.d.003 Influences of environmental enrichment on the effects heroin Solinas, M.
 2008
 18 Supplement 4 p. S541-
1 p.
 artikel
66 P.2.d.023 In vitro pharmacological profile of doxepin, a sleep-promoting histamine H1 antagonist Mansbach, R.
 2008
 18 Supplement 4 p. S357-S358
2 p.
 artikel
67 P.2.e.015 Antiepileptic mood stabilizers (carbamazepine and valproate) in acute-phase psychotic bipolar mania treatment Totic, S.
 2008
 18 Supplement 4 p. S367-S368
2 p.
 artikel
68 P.1.e.011 Brain correlates of theory of mind in the early course of schizophrenia Herold, R.
 2008
 18 Supplement 4 p. S265-
1 p.
 artikel
69 P.3.e.006 Efficacy of risperidone in prevention of relapses in patients with schizophrenia Cadikovska, N.
 2008
 18 Supplement 4 p. S465-
1 p.
 artikel
70 P.2.e.012 Gender differencies in the treatment of severe bipolar affective and schyzoaffective disorders Cobo, J.
 2008
 18 Supplement 4 p. S365-S366
2 p.
 artikel
71 P.3.e.016 Humanistic and economic outcomes associated with negative symptoms in patients with schizophrenia Kleinman, L.
 2008
 18 Supplement 4 p. S470-S471
2 p.
 artikel
72 P.1.14 Epigenetic down-regulation of atrial natriuretic peptide mRNA expression in females with eating disorders Frieling, H.
 2008
 18 Supplement 4 p. s13-
1 p.
 artikel
73 P.3.e.003 Predictors of abnormal involuntary movement in an African schizophrenia population Botha, U.A.
 2008
 18 Supplement 4 p. S463-
1 p.
 artikel
74 P.4.e.001 The change of biogenic amines and cortisol in posttraumatic stress disorder after long-term pharmacological treatment Chung, M.
 2008
 18 Supplement 4 p. S497-
1 p.
 artikel
75 P.5.e.001 The role of glutamate dehydrogenase activity in neuroexcitotoxic glutamate developement Kravos, M.
 2008
 18 Supplement 4 p. S515-
1 p.
 artikel
76 P.6.e.001 Verbal memory deficits in dual diagnosis patients analyzed with the free recall method Krysta, K.
 2008
 18 Supplement 4 p. S549-
1 p.
 artikel
77 P.1.g.002 Aspects of working memory performance in first-episode of schizophrenia patients and healthy siblings Ghirasim, N.
 2008
 18 Supplement 4 p. S274-
1 p.
 artikel
78 P.2.g.004 Changes of depressive symptoms after antidepressant treatment in the patients with chronic hemodialysis and depression Park, S.
 2008
 18 Supplement 4 p. S375-
1 p.
 artikel
79 P.1.31 Gender-related differences in synaptic transmission and plasticity in the mouse striatum and nucleus accumbens Schotanus, S.M.
 2008
 18 Supplement 4 p. s26-s27
nvt p.
 artikel
80 P.1.g.005 Improving metabolic health outcomes in mentally ill populations with the Mieux-Être Wellness program Shriqui, C.
 2008
 18 Supplement 4 p. S275-S276
2 p.
 artikel
81 P.1.g.019 RY-023, an inverse agonist at alpha5 GABAA receptors: the influence on spatial memory and spontaneous locomotor activity Milinkovic, M.M.
 2008
 18 Supplement 4 p. S284-
1 p.
 artikel
82 Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and d-serine Hashimoto, Kenji
 2008
 18 Supplement 4 p. 414-421
8 p.
 artikel
83 P.2.h.005 Serotonin levels and lymphocyte populations in female patients with depression: a comparative study Figueiredo, M.
 2008
 18 Supplement 4 p. S384-S385
2 p.
 artikel
84 P.1.i.008 A link between the serotonin transporter and oxytocin Marazziti, D.
 2008
 18 Supplement 4 p. S292-
1 p.
 artikel
85 P.2.22 Impact of behavioural sensitization to methamphetamine on i.v. selfadminitration of the drug in male and female rats Kucerova, J.
 2008
 18 Supplement 4 p. s54-s55
nvt p.
 artikel
86 P.1.28 Modulation of intracellular signaling patwhays by acute swim stress in rat hippocampus Pasini, M.
 2008
 18 Supplement 4 p. s24-
1 p.
 artikel
87 P.3.23 Molecular imaging of early visual cortex by combining pet and fMRI Gerstl, F.
 2008
 18 Supplement 4 p. s81-s82
nvt p.
 artikel
88 P.3.09 The predictive value of neurocognitive decision-making for heavy alcohol use in a longitudinal, prospective study Goudriaan, A.
 2008
 18 Supplement 4 p. s69-s70
nvt p.
 artikel
89 P.3.06 Tryptophan degradation in psychosis: simultaneous measurement of tryptophan and kynurenine pathway metabolites by HPLC Clarke, G.
 2008
 18 Supplement 4 p. s67-s68
nvt p.
 artikel
90 S.04.08 Adolescent cannabinoid exposure induces sex dependent alterations in adulthood: behavioural and biochemical evidences Realini, N.
 2008
 18 Supplement 4 p. S163-
1 p.
 artikel
91 S.24.02 Chronic stress changes neurosteroids content and neuronal plasticity in the rat brain Biggio, G.
 2008
 18 Supplement 4 p. S191-
1 p.
 artikel
92 S.22.01 From traumatic events to symptoms: a prospective-longitudinal investigation in the community Wittchen, H.
 2008
 18 Supplement 4 p. S187-
1 p.
 artikel
93 S.11.05 Functional MRI in small animals: applications to animal models of anxiety disorders Mueggler, T.
 2008
 18 Supplement 4 p. S175-
1 p.
 artikel
94 S.02.01 Molecular genetic findings in suicide: what lies beyond the serotonergic system? Reif, A.
 2008
 18 Supplement 4 p. S156-S157
2 p.
 artikel
95 S.1.01 Neuropeptidergic mechanisms and mental disease Hökfelt, T.
 2008
 18 Supplement 4 p. s1-s2
nvt p.
 artikel
96 S.24.05 Neurosteroids mediate alcohol sensitivity: mechanisms and therapeutic relevance Morrow, A.L.
 2008
 18 Supplement 4 p. S192-
1 p.
 artikel
97 S.07.05 Proline affects brain function in 22q11DS children with the low-activity COMT158 allele Vorstman, J.A.S.
 2008
 18 Supplement 4 p. S168-S169
2 p.
 artikel
98 S.02.04 Suicide prevention in bipolar disorder: a reality? Isometsä, E.T.
 2008
 18 Supplement 4 p. S157-S158
2 p.
 artikel
99 S.18.02 The treatment of treatment-resistant adolescents with depression Emslie, G.
 2008
 18 Supplement 4 p. S182-
1 p.
 artikel
100 Strategies of treatment with olanzapine in schizophrenic patients during stable phase: Results of a pilot study Rouillon, Frédéric
 2008
 18 Supplement 4 p. 646-652
7 p.
 artikel
101 S.07.08 Using pharmacological fMRI to examine the effect of an SSRI on the neural circuitry underpinning threat processing Murphy, S.
 2008
 18 Supplement 4 p. S170-
1 p.
 artikel
102 Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole Kwon, Jun Soo
 2008
 18 Supplement 4 p. 897-907
11 p.
 artikel
103 Time dependent alterations on tyrosine hydroxylase, opioid and cannabinoid CB1 receptor gene expressions after acute ethanol administration in the rat brain Oliva, José M.
 2008
 18 Supplement 4 p. 373-382
10 p.
 artikel
104 Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder Hernández, María Eugenia
 2008
 18 Supplement 4 p. 917-924
8 p.
 artikel
                             104 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland